Probiotic may be helpful in treating colic in infants


  • Mary Corcoran
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Supplementation with the probiotic strain Bifidobacterium animalis subsp. lactis BB-12 (BB-12) could be helpful in treating colic in infants, suggest findings from a new trial which have just been published in Alimentary Pharmacology & Therapeutics. 

The trial randomised 80 exclusively breastfed infants with colic, who were otherwise healthy, to receive BB-12 (n=40) or placebo (n=40) for 28 days. Parents were asked to administer six drops of the assigned product to the infants once daily. 

The authors reported that infants in the BB‐12 group presented a significantly higher reduction in crying duration after 28 days of treatment compared to the placebo group (P<.0001 the duration of daily crying was reduced by more than per cent in who received probiotic with beneficial effects on sleep and stool frequency consistency only infants placebo.>

The authors said the finding provides further evidence of the important role of gut microbiota as a target of intervention against colic. They noted that the trial studied a specific well‐characterised probiotic strain and that these findings cannot be extrapolated for other probiotic strains.